Implantable Bioartificial Pancreas for Treating Type 1 Diabetes

Note: The following ratings and comments reflect the opinions and consensus of an expert panel convened by ECRI Institute to review information on this topic.

Anticipated Utilization: 3(Expected to be used by 40% to 60% of eligible patients)

The American Association of Clinical Endocrinologists, the U.S. Food and Drug Administration (FDA), and a few independent investment research firms estimate 350,000 to 515,000 people use insulin pumps in the United States. We expect 40% to 60% of these pump users (140,000 to 309,000) would use a bioartificial pancreas to actively manage blood glucose levels and insulin administration, if it was approved by FDA and was determined to be both safe and effective in the long term.

Estimated Adoption Status: 1 (Early...